Thomas Beetham
Overview
Thomas Beetham received an average of $2M in total compensation, including $265K in salary, at Dianthus Therapeutics between 2021 and 2023. Thomas Beetham also received $5M at Signal Genetics in 2023.
Source: SEC filings on April 11, 2024, April 26, 2024, and May 2, 2022.
Related executives
We found 23 more executives who work or worked at Dianthus Therapeutics and Signal Genetics.
Scott Myers
Signal Genetics
Chief Executive Officer
Stephen Mahoney
Signal Genetics
Chief Executive Officer
Seth Harmon
Signal Genetics
Senior Vice President of Finance and Accounting
Jonathan Violin
Signal Genetics
Chief Executive Officer
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
Simrat Randhawa
Dianthus Therapeutics